AstraZeneca Charts Comprehensive Anti-Obesity Strategy with GLP-1 and Amylin Therapies
AstraZeneca (AZ; NASDAQ: AZN), a UK-based pharmaceutical giant, has outlined its strategic advancements and future...
Bristol-Myers Squibb Q2 2024 Sales Boosted by Growth Portfolio, Offset by R&D Impairment
Bristol-Myers Squibb (BMS; NYSE: BMY) has announced its financial results for the second quarter of...
3SBio’s Thrombopoietin Meets Primary Endpoint in Phase III Trial for Chronic Liver Disease Patients
3SBio Inc. (HKG: 1530), a biopharmaceutical company based in China, has announced the successful conclusion...
CStone Pharmaceuticals’ Sugemalimab Wins EU Nod as First-Line NSCLC Treatment
CStone Pharmaceuticals (HKG: 2616), a leading biopharmaceutical company based in China, has received marketing approval...
Alphamab’s KN057 Earns FDA Orphan Drug Designation for Hemophilia B Treatment
Alphamab Oncology (HKG: 9966), a biopharmaceutical company based in China, has received another orphan drug...
Junshi Biosciences’ Toripalimab Recommended for EU Approval for Two Indications
Shanghai Junshi Biosciences Co., Ltd (HKG: 1877; SHA: 688180) has been recommended for approval by...
Akeso Biopharma’s Ivonescimab NDA Accepted by NMPA, Strengthening NSCLC Treatment Options
Akeso Biopharma (HKG: 9926), a biopharmaceutical company based in China, has received a significant boost...
Beijing Balance Medical Secures NMPA Nod for Pioneering Heart Valve Patch
Beijing Balance Medical Technology Co., Ltd (SHA: 688198), a leading medical technology firm based in...
Hengrui Pharmaceuticals Advances in Breast Cancer Treatment with NMPA Clinical Trial Greenlight
Jiangsu Hengrui Pharmaceuticals Co., Ltd (SHA: 600276), a pharmaceutical heavyweight based in China, has received...
MicroPort MedTech’s Aortic Occlusion Catheter Gets Green Light from China’s NMPA
Shanghai MicroPort Endovascular MedTech Co., Ltd (SHA: 688016), a leading player in the medical technology...
Zhejiang Haichang Biotech Secures EU Approval for Apexelsin: A New Hope in Cancer Treatment
Zhejiang Haichang Biotech Co., Ltd, a partner of China-based Kexing Pharmaceutical (SHA: 688136), has secured...
China Unveils Comprehensive 2030 Plan to Combat Diabetes
China’s National Health Commission (NHC), in collaboration with 12 other ministries, has unveiled the ‘Health...
CNBG and University of Macau Ink Deal to Establish Joint Biotech Lab
China National Biotec Group Company Ltd (CNBG) has announced a strategic collaboration with the University...
Tigermed Expands Asia Pacific Presence with Acquisition of Japanese CRO Medical Edge
Tigermed (SHE: 300347, HKG: 3347), a leading China-based Contract Research Organization (CRO), has announced the...
Shanghai Escugen Partners with Innolake Biopharma to Develop Novel ADCs Using EZWi-Fit Platfo
Shanghai Escugen, a Chinese biopharmaceutical company, has entered into a strategic partnership with fellow Chinese...
Belief BioMed’s Hemophilia B Gene Therapy BBM-H901 Slated for Priority Review in China
The Center for Drug Evaluation (CDE) has indicated on its website that the market application...
NHSA Report: China’s Medical Insurance Fund Records Significant Growth and Savings in 2023
The National Healthcare Security Administration (NHSA) has released its comprehensive annual statistical report for the...
CanSino Biologics Partners with Malaysia’s NIBM to Develop mRNA Influenza Vaccine
CanSino Biologics Inc. (HKG: 6185), a leading Chinese biotechnology company, has entered into a strategic...
Shanghai’s Spectrum Dynamics Medical Secures Major Financing for Molecular Imaging Innovations
Spectrum Dynamics Medical, a Shanghai-based specialist in medical molecular imaging, has reportedly secured hundreds of...
Shanghai GenTech Expands into Life Sciences with Acquisition of Konosai Biotechnology
Shanghai GenTech Co., Ltd., a Chinese solutions provider with expertise in flat panel display, LED,...